WO2009072628A1 - ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体 - Google Patents
ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体 Download PDFInfo
- Publication number
- WO2009072628A1 WO2009072628A1 PCT/JP2008/072198 JP2008072198W WO2009072628A1 WO 2009072628 A1 WO2009072628 A1 WO 2009072628A1 JP 2008072198 W JP2008072198 W JP 2008072198W WO 2009072628 A1 WO2009072628 A1 WO 2009072628A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- growth factor
- binding
- monoclonal antibody
- heparin
- antibody capable
- Prior art date
Links
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title 1
- 239000003102 growth factor Substances 0.000 title 1
- 230000010005 growth-factor like effect Effects 0.000 title 1
- 229960002897 heparin Drugs 0.000 title 1
- 229920000669 heparin Polymers 0.000 title 1
- 102000018710 Heparin-binding EGF-like Growth Factor Human genes 0.000 abstract 4
- 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 abstract 4
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2707689A CA2707689A1 (en) | 2007-12-05 | 2008-12-05 | Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
AU2008332296A AU2008332296A1 (en) | 2007-12-05 | 2008-12-05 | Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
CN2008801262682A CN101978054B (zh) | 2007-12-05 | 2008-12-05 | 能够与肝素结合性表皮生长因子样生长因子结合的单克隆抗体 |
JP2009544756A JP5532401B2 (ja) | 2007-12-05 | 2008-12-05 | ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体 |
EP08857234A EP2221374A4 (en) | 2007-12-05 | 2008-12-05 | MONOCLONAL ANTIBODY CAPABLE OF BINDING TO A GROWTH FACTOR OF HB-EGF (HEPARIN-BINDING EPIDERMAL GROWTH FACTOR) |
US12/609,434 US8163282B2 (en) | 2007-12-05 | 2009-10-30 | Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
US13/428,787 US20130337505A1 (en) | 2007-12-05 | 2012-03-23 | Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007315068 | 2007-12-05 | ||
JP2007-315068 | 2007-12-05 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/609,434 Continuation US8163282B2 (en) | 2007-12-05 | 2009-10-30 | Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009072628A1 true WO2009072628A1 (ja) | 2009-06-11 |
Family
ID=40717806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/072198 WO2009072628A1 (ja) | 2007-12-05 | 2008-12-05 | ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体 |
Country Status (8)
Country | Link |
---|---|
US (2) | US8163282B2 (ja) |
EP (1) | EP2221374A4 (ja) |
JP (1) | JP5532401B2 (ja) |
KR (1) | KR20100097674A (ja) |
CN (1) | CN101978054B (ja) |
AU (1) | AU2008332296A1 (ja) |
CA (1) | CA2707689A1 (ja) |
WO (1) | WO2009072628A1 (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011021381A1 (ja) * | 2009-08-17 | 2011-02-24 | 株式会社未来創薬研究所 | 抗hb-egf抗体を有効成分として含む医薬組成物 |
WO2013140335A1 (fr) | 2012-03-20 | 2013-09-26 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Inhibiteur de l'hb-egf dérivé du domaine r de la toxine diphtérique pour le traitement des maladies associées a l'activation de la voie hb-egf/egfr |
WO2014175160A1 (ja) * | 2013-04-23 | 2014-10-30 | 株式会社医学生物学研究所 | ヘパリン結合上皮増殖因子様増殖因子に対する機能性モノクローナル抗体 |
US8975374B2 (en) | 2006-10-20 | 2015-03-10 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient |
US9023993B2 (en) | 2006-10-20 | 2015-05-05 | Chugai Seiyaku Kabushiki Kaisha | Anti-cancer agent comprising anti-HB-EGF antibody as active ingredient |
JP5806935B2 (ja) * | 2009-08-17 | 2015-11-10 | 中外製薬株式会社 | 抗hb−egf抗体を有効成分として含む医薬組成物 |
JP5838427B2 (ja) * | 2013-04-23 | 2016-01-06 | 株式会社医学生物学研究所 | ヘパリン結合上皮増殖因子様増殖因子に対する機能性モノクローナル抗体 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090029227A (ko) | 2006-06-06 | 2009-03-20 | 교와 핫꼬 기린 가부시키가이샤 | 헤파린 결합 상피세포 증식 인자 유사 증식 인자에 결합하는 모노클로날 항체 |
JP5299922B2 (ja) * | 2009-02-04 | 2013-09-25 | 国立大学法人大阪大学 | Hb−egf結合性タンパク質複合体 |
US11161911B2 (en) | 2017-10-23 | 2021-11-02 | Go Therapeutics, Inc. | Anti-glyco-MUC1 antibodies and their uses |
BR112020008001A2 (pt) * | 2017-10-24 | 2020-10-20 | Go Therapeutics, Inc. | anticorpo anti-glico-muc1 ou fragmento de ligação de antígeno, proteína de fusão, receptor de antígeno quimérico, conjugado de anticorpo-fármaco, ácido nucleico, vetor, célula hospedeira, composição farmacêutica, e, métodos de tratar câncer e de detectar câncer em uma amostra biológica. |
CN109580959B (zh) * | 2018-12-17 | 2020-03-31 | 江苏莱森生物科技研究院有限公司 | 一种检测肝素结合性表皮生长因子的elisa试剂盒 |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5623587A (en) | 1979-08-03 | 1981-03-05 | Mitsuwa Seiki Co Ltd | Vane type compressor |
JPS58110600A (ja) | 1981-12-25 | 1983-07-01 | Kyowa Hakko Kogyo Co Ltd | ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド |
JPS60221091A (ja) | 1983-12-21 | 1985-11-05 | Kyowa Hakko Kogyo Co Ltd | 新規プロモ−タ− |
JPS61178926A (ja) | 1984-03-06 | 1986-08-11 | Takeda Chem Ind Ltd | 化学修飾ペプチドホルモンおよびその製造法 |
JPS63299A (ja) | 1986-04-22 | 1988-01-05 | イミユネツクス・コ−ポレ−シヨン | ヒトg−csfタンパク質の発現 |
JPH02117920A (ja) | 1988-05-06 | 1990-05-02 | Sumitomo Pharmaceut Co Ltd | ポリエチレングリコール誘導体、修飾ペプチドおよびその製造方法 |
US4939094A (en) | 1985-08-28 | 1990-07-03 | Kyowa Hakko Kogyo Co., Ltd. | Fused antigen polypeptide |
JPH02227075A (ja) | 1988-09-29 | 1990-09-10 | Kyowa Hakko Kogyo Co Ltd | 新規ポリペプチド |
JPH02257891A (ja) | 1989-03-31 | 1990-10-18 | Kyowa Hakko Kogyo Co Ltd | 組換え動物細胞による蛋白質の製造 |
JPH0322979A (ja) | 1989-06-19 | 1991-01-31 | Kyowa Hakko Kogyo Co Ltd | 新規プラスミノーゲン活性化因子 |
JPH05336963A (ja) | 1991-12-17 | 1993-12-21 | Kyowa Hakko Kogyo Co Ltd | 新規α2→3シアリルトランスフェラーゼ |
WO1994023021A1 (en) | 1993-03-29 | 1994-10-13 | Kyowa Hakko Kogyo Co., Ltd. | α-1,3-FUCOSYLTRANSFERASE |
WO1997010354A1 (en) | 1995-09-11 | 1997-03-20 | Kyowa Hakko Kogyo Co., Ltd. | ANTIBODY AGAINTS α-CHAIN OF HUMAN INTERLEUKIN 5 RECEPTOR |
US20040253234A1 (en) | 2001-06-28 | 2004-12-16 | Kenya Shitara | Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof |
WO2007142277A1 (ja) * | 2006-06-06 | 2007-12-13 | Kyowa Hakko Kirin Co., Ltd. | ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3040347A3 (en) * | 2006-10-20 | 2016-09-21 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
US9023993B2 (en) * | 2006-10-20 | 2015-05-05 | Chugai Seiyaku Kabushiki Kaisha | Anti-cancer agent comprising anti-HB-EGF antibody as active ingredient |
-
2008
- 2008-12-05 WO PCT/JP2008/072198 patent/WO2009072628A1/ja active Application Filing
- 2008-12-05 EP EP08857234A patent/EP2221374A4/en not_active Withdrawn
- 2008-12-05 KR KR1020107012395A patent/KR20100097674A/ko not_active Application Discontinuation
- 2008-12-05 AU AU2008332296A patent/AU2008332296A1/en not_active Abandoned
- 2008-12-05 JP JP2009544756A patent/JP5532401B2/ja not_active Expired - Fee Related
- 2008-12-05 CA CA2707689A patent/CA2707689A1/en not_active Abandoned
- 2008-12-05 CN CN2008801262682A patent/CN101978054B/zh not_active Expired - Fee Related
-
2009
- 2009-10-30 US US12/609,434 patent/US8163282B2/en not_active Expired - Fee Related
-
2012
- 2012-03-23 US US13/428,787 patent/US20130337505A1/en not_active Abandoned
Patent Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5623587A (en) | 1979-08-03 | 1981-03-05 | Mitsuwa Seiki Co Ltd | Vane type compressor |
JPS58110600A (ja) | 1981-12-25 | 1983-07-01 | Kyowa Hakko Kogyo Co Ltd | ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド |
US4686191A (en) | 1981-12-25 | 1987-08-11 | Hakko Kogyo Co., Ltd. Kyowa | Recombinant plasmid containing human interferon-beta gene |
JPS60221091A (ja) | 1983-12-21 | 1985-11-05 | Kyowa Hakko Kogyo Co Ltd | 新規プロモ−タ− |
JPS61178926A (ja) | 1984-03-06 | 1986-08-11 | Takeda Chem Ind Ltd | 化学修飾ペプチドホルモンおよびその製造法 |
US4939094A (en) | 1985-08-28 | 1990-07-03 | Kyowa Hakko Kogyo Co., Ltd. | Fused antigen polypeptide |
JPS63299A (ja) | 1986-04-22 | 1988-01-05 | イミユネツクス・コ−ポレ−シヨン | ヒトg−csfタンパク質の発現 |
JPH02117920A (ja) | 1988-05-06 | 1990-05-02 | Sumitomo Pharmaceut Co Ltd | ポリエチレングリコール誘導体、修飾ペプチドおよびその製造方法 |
JPH02227075A (ja) | 1988-09-29 | 1990-09-10 | Kyowa Hakko Kogyo Co Ltd | 新規ポリペプチド |
JPH02257891A (ja) | 1989-03-31 | 1990-10-18 | Kyowa Hakko Kogyo Co Ltd | 組換え動物細胞による蛋白質の製造 |
JPH0322979A (ja) | 1989-06-19 | 1991-01-31 | Kyowa Hakko Kogyo Co Ltd | 新規プラスミノーゲン活性化因子 |
US5160735A (en) | 1989-06-19 | 1992-11-03 | Kyowa Hakko Kogyo Co. Ltd. | Plasminogen activator |
JPH05336963A (ja) | 1991-12-17 | 1993-12-21 | Kyowa Hakko Kogyo Co Ltd | 新規α2→3シアリルトランスフェラーゼ |
WO1994023021A1 (en) | 1993-03-29 | 1994-10-13 | Kyowa Hakko Kogyo Co., Ltd. | α-1,3-FUCOSYLTRANSFERASE |
WO1997010354A1 (en) | 1995-09-11 | 1997-03-20 | Kyowa Hakko Kogyo Co., Ltd. | ANTIBODY AGAINTS α-CHAIN OF HUMAN INTERLEUKIN 5 RECEPTOR |
US20040253234A1 (en) | 2001-06-28 | 2004-12-16 | Kenya Shitara | Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof |
WO2007142277A1 (ja) * | 2006-06-06 | 2007-12-13 | Kyowa Hakko Kirin Co., Ltd. | ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体 |
Non-Patent Citations (134)
Title |
---|
"Funakoshi Sogo Catalog 2005-2006 Shiyakuhen [Kotai]", 22 December 2005, pages: 474 * |
AGRIC. BIOL. CHEM., vol. 53, 1989, pages 277 |
AGRICULTURAL BIOLOGICAL CHEMISTRY, vol. 48, 1984, pages 669 |
AM. J PATHOL., vol. 143, 1993, pages 784 - 793 |
ARTERIOSCLER. THROMB. VASC. BIOL., vol. 16, 1996, pages 1524 - 1531 |
BIO/TECHNOLOGY, vol. 10, no. 16, 1992, pages 3 - 167 |
BIO/TECHNOLOGY, vol. 2, 1991, pages 266 - 271 |
BIO/TECHNOLOGY, vol. 9, 1991, pages 266 - 271 |
BIOCHEM BIOPHYS, RES. COMMUN., vol. 198, 1994, pages 25 - 31 |
BIOCHEM. BIOPHYS. ACTA, vol. 1333, 1997, pages F179 |
BIOCHEM. BIOPHYS. RES. COMMUN., vol. 149, 1987, pages 960 - 968 |
BIOCHEM. BIOPHYS. RES. COMMUN., vol. 202, 1994, pages 1705 |
BLOOD, vol. 65, 1985, pages 1349 |
BRAIN RES., vol. 827, 1999, pages 130 - 138 |
BREAST CANCER RES. TREAT., vol. 67, 2001, pages 81 |
CANCER RES., vol. 46, 1986, pages 6489 |
CANCER RES., vol. 52, 1992, pages 3402 |
CANCER RES., vol. 56, 1996, pages 1118 |
CANCER RES., vol. 61, 2001, pages 6227 |
CANCER RES., vol. 64, 2004, pages 5283 |
CANCER RES., vol. 64, 2004, pages 5720 |
CELL, vol. 33, 1983, pages 717 - 728 |
CELL, vol. 41, 1985, pages 479 - 487 |
CELL, vol. 69, 1992, pages 1051 |
CLIN. CANCER RES., vol. 11, 2005, pages 4639 |
CLIN. CANCER RES., vol. 11, 2005, pages 4783 |
COHEN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 69, 1972, pages 2110 |
CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, vol. 18, 1978, pages 1 - 7 |
CYTOKINE GROWTH FACTOR REV., vol. 11, 2000, pages 335 |
CYTOTECHNOL., vol. 1, 1990, pages 173 - 180 |
CYTOTECHNOL., vol. 3, 1990, pages 133 - 140 |
CYTOTECHNOLOGY, vol. 3, 1990, pages 133 |
CYTOTECHNOLOGY, vol. 3, 1990, pages 133 - 140 |
CYTOTECHNOLOGY, vol. J, 1990, pages 133 |
DNA CLONING: A PRACTICAL APPROACH, vol. 1, 1985, pages 49 |
EMB O J, vol. 20, 2001, pages 3342 - 3350 |
EMBO J, vol. 16, 1997, pages 1268 - 1278 |
EUROPEAN J IMMUNOLOGY, vol. 2, 1976, pages 511 - 519 |
GENE, vol. 17, 1982, pages 107 |
GENE, vol. 27, 1984, pages 223 - 232 |
GENE, vol. 33, 1985, pages 103 - 119 |
GENE, vol. 34, 1985, pages 315 |
GENE, vol. 38, 1985, pages 275 - 276 |
GENES DEVELOP., vol. 4, 1990, pages 1288 |
GENETICS, vol. 59, 1968, pages 177 - 190 |
GENOME RES., vol. 7, 1997, pages 649, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/Education/BLASTinformation3.html> |
HEPATOLOGY, vol. 22, 1995, pages 1584 - 1590 |
HUMAN ANTIBODIES & HYBRIDOMAS, vol. 5, 1994, pages 48 - 56 |
HUMAN ANTIBODIES HYBRIDOMAS, vol. 5, 1994, pages 48 |
HYBRIDOMA, vol. 17, 1998, pages 559 - 567 |
IMMUNOL., vol. 85, 1995, pages 668 |
INT. J. CANCER, vol. 98, 2002, pages 505 |
J BIOL. CHEM., vol. 267, 1992, pages 6205 - 6212 |
J BIOL. CHEM., vol. 269, 1994, pages 20060 - 20066 |
J BIOL. CHEM., vol. 271, 1996, pages 2966 |
J BIOL. CHEM., vol. 277, 2002, pages 37487 - 37491 |
J CELL BIOL., vol. 128, 1995, pages 929 - 938 |
J CELL BIOL., vol. 129, 1995, pages 1691 - 1705 |
J CELL BIOL., vol. 151, 2000, pages 209 - 219 |
J HISTOCHEM. CYTOCHEM, vol. 49, 2001, pages 439 |
J IMMUNOLOGY, vol. 123, 1979, pages 1548 - 1550 |
J MOL. BIOL., vol. 215, 1990, pages 403 |
J PATHOL., vol. 189, 1999, pages 431 - 438 |
J. BIOCHEM., vol. 101, 1987, pages 1307 - 1310 |
J. BIOCHEMISTRY, vol. 101, 1987, pages 1307 |
J. BIOL. CHEM., vol. 270, 1995, pages 1015 |
J. CLIN. INVEST., vol. 95, 1995, pages 404 |
J. CLIN.ONCOL., vol. 2, 1984, pages 881 |
J. IMMUNOL., vol. 144, 1990, pages 1382 |
J. OF CELL BIOLOGY, vol. 163, 2003, pages 469 |
J.IMMUNOL., vol. 135, 1985, pages 1530 |
J.NATL.CANCER INST., vol. 80, 1988, pages 932 |
J.NATL.CANCER INST., vol. 80, 1988, pages 937 |
J.NUCL.MED., vol. 26, 1985, pages 1011 |
JOURNAL OF BIOTECHNOLOGY, vol. 23, 1992, pages 271 - 289 |
JOURNAL OF IMMUNOLOGICAL METHODS, vol. 167, 1994, pages 271 - 278 |
JOURNAL OF MOLECULAR BIOLOGY, vol. 112, 1977, pages 535 - 542 |
JOURNAL OF MOLECULAR BIOLOGY, vol. 16, 1966, pages 118 - 133 |
JOURNAL OF MOLECULAR BIOLOGY, vol. 166, 1983, pages 1 - 19 |
JOURNAL OF MOLECULAR BIOLOGY, vol. 215, 1990, pages 403 - 410 |
LOWE ET AL., PROC. NATL. ACAD SCI. USA, vol. 86, 1989, pages 8227 |
MCCARTHY, S. A. ET AL.: "Rapid induction of heparin-binding epidermal growth factor/ diphtheria toxin receptor expression by Raf and Ras oncogenes.", GENES AND DEVELOPMENT, vol. 9, 1995, pages 1953 - 1964 * |
MEKADA ET AL., J BIO. CHEM., vol. 272, 1997, pages 27084 - 27090 |
METHODS IN ENZYMOLOGY, vol. 154, 1987, pages 3 - 28 |
METHODS IN ENZYMOLOGY, vol. 183, 1990, pages 63 |
MIYAMOTO, S. ET AL.: "Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy.", CANCER SCI., vol. 97, no. 5, May 2006 (2006-05-01), pages 341 - 347 * |
MOLECULAR & GENERAL GENETICS, vol. 168, 1979, pages 111 |
MOLECULAR &CELLULAR BIOLOGY, vol. 3, 1983, pages 280 - 289 |
MOLECULAR IMMUNOL., vol. 32, 1995, pages 249 |
NAT, MED., vol. 8, 2002, pages 35 |
NAT. REV. DRUG. DISCOV., vol. 2, 2003, pages 52 - 62 |
NATURE BIOTECHNOL., vol. 15, 1997, pages 629 |
NATURE, vol. 227, 1970, pages 680 - 685 |
NATURE, vol. 256, 1975, pages 495 - 497 |
NATURE, vol. 276, 1978, pages 269 - 270 |
NATURE, vol. 322, 1988, pages 323 |
NATURE, vol. 329, 1987, pages 840 |
NATURE, vol. 402, 1999, pages 884 |
NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 |
NUCLEIC ACIDS RESEARCH, vol. 10, 1982, pages 6487 |
NUCLEIC ACIDS RESEARCH, vol. 13, 1985, pages 4431 |
NUCLEIC ACIDS RESEARCH, vol. 17, 1989, pages 9494 |
ONCOL. REP., vol. 8, 2001, pages 903 |
PAULSON ET AL., J BIOL. CHEM., vol. 264, 1989, pages 17619 |
PNAS, vol. 100, 2003, pages 3221 |
PNAS, vol. 100, no. 100, 2003, pages 3221 - 3226 |
PROC. NALL ACAD. SCI. USA, vol. 79, 1982, pages 6409 |
PROC. NATL. ACAD SCI. U.S.A., vol. 90, 1993, pages 3889 - 3893 |
PROC. NATL. ACAD. SCI USA, vol. 82, 1985, pages 488 |
PROC. NATL. ACAD. SCI. USA, vol. 69, 1972, pages 2110 |
PROC. NATL. ACAD. SCI. USA, vol. 82, 1985, pages 4306 |
PROC. NATL. ACAD. SCI. USA, vol. 82, 1985, pages 488 |
PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 7413 |
PROC. NATL. ACAD. SCI., USA, vol. 79, 1982, pages 6409 |
PROC.NATL.ACAD.SCI. USA, vol. 82, 1985, pages 1242 |
PROCEEDING OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, vol. 73, 1950, pages 1 |
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 74, 1977, pages 5463 - 5467 |
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 77, 1980, pages 4216 - 4220 |
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 78, 1981, pages 1527 - 1531 |
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 84, 1987, pages 7413 - 7417 |
PROTEIN ENGINEERING, vol. 1, 1994, pages 697 |
PROTEIN ENGINEERING, vol. 7, 1994, pages 697 - 704 |
PROTEIN ENGINEERING, vol. Z, 1994, pages 1501 - 1507 |
REITER ET AL., PROTEIN ENGINEERING, vol. 1, 1994, pages 697 - 704 |
SCIENCE, vol. 122, 1952, pages 501 |
SCIENCE, vol. 222, 1983, pages 778 - 782 |
SCIENCE, vol. 240, 1988, pages 1041 - 1043 |
SCIENCE, vol. 242, 1988, pages 423 |
SCIENCE, vol. 251, 1991, pages 936 |
See also references of EP2221374A4 |
STRATEGIES, vol. 5, 1992, pages 58 - 61 |
THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, vol. 199, 1967, pages 519 |
VIROLOGY, vol. 8, 1959, pages 396 |
YOTSUMOTO, F. ET AL.: "Validation of HB-EGF and amphiregulin as targets for human cancer therapy.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 365, 20 November 2007 (2007-11-20), pages 555 - 561 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8975374B2 (en) | 2006-10-20 | 2015-03-10 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient |
US9023993B2 (en) | 2006-10-20 | 2015-05-05 | Chugai Seiyaku Kabushiki Kaisha | Anti-cancer agent comprising anti-HB-EGF antibody as active ingredient |
WO2011021381A1 (ja) * | 2009-08-17 | 2011-02-24 | 株式会社未来創薬研究所 | 抗hb-egf抗体を有効成分として含む医薬組成物 |
CN102574917A (zh) * | 2009-08-17 | 2012-07-11 | 株式会社未来创药研究所 | 含有抗hb-egf抗体作为有效成分的药物组合物 |
JP5806935B2 (ja) * | 2009-08-17 | 2015-11-10 | 中外製薬株式会社 | 抗hb−egf抗体を有効成分として含む医薬組成物 |
WO2013140335A1 (fr) | 2012-03-20 | 2013-09-26 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Inhibiteur de l'hb-egf dérivé du domaine r de la toxine diphtérique pour le traitement des maladies associées a l'activation de la voie hb-egf/egfr |
WO2014175160A1 (ja) * | 2013-04-23 | 2014-10-30 | 株式会社医学生物学研究所 | ヘパリン結合上皮増殖因子様増殖因子に対する機能性モノクローナル抗体 |
WO2014174596A1 (ja) * | 2013-04-23 | 2014-10-30 | 株式会社医学生物学研究所 | ヘパリン結合上皮増殖因子様増殖因子に対する機能性モノクローナル抗体 |
JP5838427B2 (ja) * | 2013-04-23 | 2016-01-06 | 株式会社医学生物学研究所 | ヘパリン結合上皮増殖因子様増殖因子に対する機能性モノクローナル抗体 |
US9920117B2 (en) | 2013-04-23 | 2018-03-20 | Medical & Biological Laboratives Co., Ltd. | Functional monoclonal antibody against heparin-binding epidermal growth factor-like growth factor |
Also Published As
Publication number | Publication date |
---|---|
US20130337505A1 (en) | 2013-12-19 |
JPWO2009072628A1 (ja) | 2011-04-28 |
JP5532401B2 (ja) | 2014-06-25 |
KR20100097674A (ko) | 2010-09-03 |
CN101978054B (zh) | 2013-05-29 |
US20110034673A1 (en) | 2011-02-10 |
AU2008332296A1 (en) | 2009-06-11 |
CA2707689A1 (en) | 2009-06-11 |
EP2221374A1 (en) | 2010-08-25 |
EP2221374A4 (en) | 2011-01-19 |
CN101978054A (zh) | 2011-02-16 |
US8163282B2 (en) | 2012-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009072628A1 (ja) | ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体 | |
MX2010003380A (es) | Proteinas de union a antigeno de factor de crecimiento tipo factor de crecimiento epidermico de union a heparina. | |
WO2010145792A8 (en) | Bispecific antigen binding proteins | |
NZ606090A (en) | Human cgrp receptor binding proteins | |
WO2010002862A3 (en) | Fibroblast growth factor receptor 3 (fgfr3) binding proteins | |
WO2010107752A3 (en) | Alpha-4-beta-7 heterodimer specific antagonist antibody | |
WO2009155180A8 (en) | Antibodies to il-6 and their uses | |
BRPI0821777B8 (pt) | anticorpo biespecífico bivalente, método para a preparação do mesmo e composição | |
PH12014502641B1 (en) | Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof | |
BR112012003809A2 (pt) | anticorpa monoclonal isolado ou porção de ligação a antígeno do mesmo, composição e, método para tratar câncer em um indivíduo. | |
WO2007116360A3 (en) | Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof | |
WO2009021754A3 (en) | Monospecific and multispecific antibodies and method of use | |
WO2010025400A3 (en) | Cross-reactive and bispecific anti-el 17a/f antibodies | |
WO2006121422A8 (en) | Antibodies against clostridium difficile toxins and uses thereof | |
WO2007080392A3 (en) | Ligands that have binding specificity for vegf and/or egfr and methods of use therefor | |
NZ592473A (en) | Urinary biomarkers for predicting long-term dialysis | |
WO2007023298A3 (en) | Antibodies | |
WO2013043933A3 (en) | Cd27l antigen binding proteins | |
EP2039704A4 (en) | MONOCLONAL ANTIBODY CAPABLE OF BINDING TO EPIDERMAL GROWTH FACTOR GROWTH FACTOR BINDING TO HEPARIN | |
WO2011075636A3 (en) | Wise binding agents and epitopes | |
WO2009051201A1 (ja) | 抗bst2抗体 | |
WO2011138557A3 (fr) | Utilisation d'anticorps anti-cd71 pour la préparation d'un médicament | |
BRPI1013177A2 (pt) | construto de ligação de antígeno, polipeptídeo isolado, e, método para tratar doença cardíaca | |
EP2105447A4 (en) | ANTIBODIES OF AVIAN ORIGIN CAPABLE OF SPECIFICALLY BINDING TO HUMAN HMGB1, METHOD OF IMMUNOLOGICAL DETERMINATION FOR HUMAN HMGB1, AND IMMUNOLOGICAL DETERMINATION REAGENT FOR HUMAN HMGB1 | |
WO2010087594A3 (ko) | 시디93 또는 이의 가용성 단편의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880126268.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08857234 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009544756 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2707689 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 20107012395 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008332296 Country of ref document: AU |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008857234 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2008332296 Country of ref document: AU Date of ref document: 20081205 Kind code of ref document: A |